Article Versions Notes

Maharjan CK, Umesalma S, Kaemmer CA, Muniz VP, Bauchle C, Mott SL, Zamba KD, Breheny P, Leidinger MR, Darbro BW, et al. RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo. Biomedicines. 2021; 9(6):633. https://doi.org/10.3390/biomedicines9060633

Maharjan, Chandra K., Shaikamjad Umesalma, Courtney A. Kaemmer, Viviane P. Muniz, Casey Bauchle, Sarah L. Mott, K. D. Zamba, Patrick Breheny, Mariah R. Leidinger, Benjamin W. Darbro, and et al. 2021. "RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo" Biomedicines 9, no. 6: 633. https://doi.org/10.3390/biomedicines9060633

Maharjan, C. K., Umesalma, S., Kaemmer, C. A., Muniz, V. P., Bauchle, C., Mott, S. L., Zamba, K. D., Breheny, P., Leidinger, M. R., Darbro, B. W., Stephens, S. B., Meyerholz, D. K., & Quelle, D. E. (2021). RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo. Biomedicines, 9(6), 633. https://doi.org/10.3390/biomedicines9060633